Información de la revista
Lo más citado
84
STAT3: A key regulator in liver fibrosisJie Zhao, Yong-Fen Qi, Yan-Rong Yu
Ann Hepatol. 2021;21C:224
84
Open access
77
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysisAshish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, ... Preeti Malik
Ann Hepatol. 2021;21C:273
77
Open access
Artículo abierto
57
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review articleMohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio
Ann Hepatol. 2021;22C:249
57
Open access
51
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studiesUmar Hayat, Ali A. Siddiqui, Hayrettin Okut, Saba Afroz, Syed Tasleem, Ahmed Haris
Ann Hepatol. 2021;20C:254
51
Open access
41
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)Ivan Lopez-Mendez, Jorge Aquino-Matus, Sofia Murua-Beltrán Gall, Jose D. Prieto-Nava, Eva Juarez-Hernandez, Misael Uribe, Graciela Castro-Narro
Ann Hepatol. 2021;20C:271
41
Open access
Artículo abierto
33
Silymarin is an ally against insulin resistance: A reviewKarla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón
Ann Hepatol. 2021;23C:255
33
Open access
32
Standardization of conventional chemoembolization for hepatocellular carcinomaMatteo Renzulli, Giuliano Peta, Francesco Vasuri, Giovanni Marasco, Daniele Caretti, Laura Bartalena, Daniele Spinelli, Emanuela Giampalma, ... Rita Golfieri
Ann Hepatol. 2021;22C:278
32
Open access
31
Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 casesFaxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei Xie, Xiang Wang, Yuanliang Xie
Ann Hepatol. 2021;21C:267
31
Open access
Artículo abierto
28
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admissionManuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, Margarita Anders, María Dolores Silveyra, Aldo Torre, Pedro Montes, Alvaro Urzúa, ... Marcelo O Silva
Ann Hepatol. 2021;21C:100298
28
Open access
Artículo abierto
25
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort studyPaulina Vidal-Cevallos, Fatima Higuera-De-La-Tijera, Norberto C. Chávez-Tapia, Francisco Sanchez-Giron, Eira Cerda-Reyes, Victor Hugo Rosales-Salyano, Alfredo Servin-Caamaño, Martín Uriel Vázquez-Medina, Nahum Méndez-Sánchez
Ann Hepatol. 2021;24C:100338
25
Open access
Artículo abierto